Absci to Participate in the BofA Securities 2021 Tech Solutions for Drug Discovery Conference
September 13, 2021 16:05 ET
|
Absci Corp
VANCOUVER, Wash., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep learning and synthetic biology to expand the therapeutic...
Absci Reports Second Quarter 2021 Financial and Operating Results
September 07, 2021 08:30 ET
|
Absci Corp
VANCOUVER, Wash., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep learning and synthetic biology to expand the therapeutic...
Absci Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
July 26, 2021 16:00 ET
|
Absci Corp
VANCOUVER, Wash., July 26, 2021 (GLOBE NEWSWIRE) -- Absci Corporation (“Absci”), the synthetic biology company unlocking the potential of proteins as next-generation therapeutics, today announced...
Absci Announces Pricing of Initial Public Offering
July 21, 2021 19:03 ET
|
Absci Corp
VANCOUVER, Wash., July 21, 2021 (GLOBE NEWSWIRE) -- Absci Corporation (“Absci”), the synthetic biology company unlocking the potential of proteins as next-generation therapeutics, today announced...